Atlastin inhibitors represent a distinctive class of chemical compounds that exert their biological effects by modulating the activity of atlastins, which are integral membrane proteins crucial for endoplasmic reticulum (ER) dynamics and intracellular membrane fusion events. Atlastins play a pivotal role in membrane tethering and fusion processes, facilitating the intricate network of membrane-bound organelles within eukaryotic cells. These proteins are particularly abundant in neurons, where they contribute significantly to the maintenance of the elaborate structure of the ER. Structurally, atlastins possess a cytoplasmic N-terminal GTPase domain, two transmembrane segments, and a C-terminal tail. The GTPase activity of atlastins is essential for their function, as it regulates their oligomerization and membrane fusion activity.
Atlastin inhibitors are designed to specifically target and modulate the GTPase activity of atlastins, thereby disrupting the finely tuned balance required for proper ER morphology and function. By impeding the GTPase cycle, these inhibitors interfere with the oligomerization and subsequent membrane tethering processes mediated by atlastins. Consequently, the dynamic membrane rearrangements crucial for cellular processes such as vesicle trafficking and organelle biogenesis are disrupted. The development of atlastin inhibitors represents a promising avenue for elucidating the intricacies of intracellular membrane dynamics and holds potential implications for understanding various cellular processes that rely on precise membrane fusion events. The study of atlastin inhibitors contributes to our broader comprehension of cell biology and may pave the way for novel strategies to manipulate intracellular membrane dynamics for experimental purposes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
NSC 23766 is a nonpeptidic inhibitor of the Rac1 GTPase, and can potentially inhibit Atlastin-1 indirectly by disrupting GTPase function. | ||||||
Rhosin | 1173671-63-0 | sc-507401 | 25 mg | $555.00 | ||
Rhosin selectively binds to RhoA subfamily of GTPases, inhibiting their function. This can indirectly affect Atlastin-1 function. | ||||||
CASIN | 425399-05-9 | sc-397016 | 10 mg | $460.00 | 1 | |
CASIN is a selective inhibitor of Cdc42 GTPase, and can potentially inhibit Atlastin-1 indirectly. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
ZCL278 is a selective inhibitor of Cdc42 GTPase, which could potentially effect Atlastin-1 indirectly. | ||||||
EHop-016 | 1380432-32-5 | sc-497382 | 5 mg | $80.00 | ||
EHop-016 is a specific Rac GTPase inhibitor, which can indirectly influence Atlastin-1. | ||||||
ITX 3 | 347323-96-0 | sc-295214 sc-295214A | 10 mg 50 mg | $145.00 $615.00 | ||
ITX3 is a specific inhibitor of Trio RhoGEFs, which can indirectly affect the function of Atlastin-1. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is a selective inhibitor of Cdc42 GTPase, and can potentially indirectly inhibit Atlastin-1. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
SecinH3 is a selective inhibitor of cytohesin GEFs, and may indirectly influence Atlastin-1 function. | ||||||
2-(Benzoylcarbamothioylamino)-5,5-dimethyl-4,7-dihydrothieno[2,3-c]pyran-3-carboxylic Acid | 314042-01-8 | sc-503400 | 10 mg | $300.00 | ||
This compound is a pan-GTPase inhibitor, and may indirectly affect Atlastin-1 function. | ||||||